Corporate News 06-Sep-23
Biocon Biologics completes integration of acquired biosimilars business from Viatris
With effect from 01 September 2023
Biocon Biologics, subsidiary of Biocon has completed the integration of the acquired biosimilars business from Viatris in North America (United States and Canada) effective 01 September 2023.
Previous News
Biocon Biologics appoints Kedar Upadhye as CFO
( Corporate News - 19-Oct-23 18:52 )
Biocon Biologics set to introduce YESAFILI®, a proposed biosimilar to EYLEA® in Canadian market
( Corporate News - 04-Mar-24 09:30 )
Biocon Biologics receives UDFDA approval for Yesafili™
( Corporate News - 21-May-24 09:13 )
Biocon Biologics divests its non-crore branded formulations biz in India
( Corporate News - 10-Nov-23 12:06 )
Biocon Biologics receives GMP certifications for its Indian and Malaysian manufacturing units
( Corporate News - 24-Jun-24 09:01 )
Biocon Biologics completes integration of acquired biosimilars business from Viatris
( Corporate News - 06-Sep-23 18:21 )
Biocon Biologics signs distribution agreement with Sandoz
( Corporate News - 22-Dec-23 19:57 )
Biocon Biologics signs settlement and license agreement with Janssen
( Corporate News - 29-Aug-24 09:03 )
Biocon Biologics concludes integration of acquired biosimilar biz in 120 countries
( Corporate News - 18-Dec-23 18:06 )
Other Stories
Tata Motors records 12% decline in Q2 sales
01-Oct-24 18:04
Tata Motors records 15% decline in September sales
01-Oct-24 17:55
Man Infra set to launch its highly anticipated Vile Parle project
01-Oct-24 17:48
Padam Cotton Yarns to declare Quarterly Result
01-Oct-24 17:39
Blueblood Ventures schedules board meeting
01-Oct-24 17:39
CRISIL to discuss results
01-Oct-24 17:39
Indian Renewable Energy Deve. Agency to convene board meeting
01-Oct-24 17:39
Ashapuri Gold Ornament schedules board meeting
01-Oct-24 17:38
Bijoy Hans to conduct board meeting
01-Oct-24 17:38
RS Software (India) to announce Quarterly Result
01-Oct-24 17:38
Back
Top
